BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ischemia
,
Kidney
,
Personalized medicine
,
Trichostatin A
,
rs2476601
,
SIRT1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
RAS pathways
Summary
General Info
Curated Studies
Most Correlated Studies
SW480 and SW620 colorectal cancer cell lines with RAS pathway genes knockdown
Acute myelogenous leukemia cells expressing activated NRAS treated with RAS pathway inhibitors
S. cerevisiae mutant with a constitutively activated Ras/cAMP pathway
Activation of Notch, Fgf, Retinoic Acid (RA), and Wnt pathways in mesoderm of RA treated embyros
Melanoma cells Ras or BRAF mutant treated with sorafenib and/or diclofenac
Explore Curated Studies Results
Literature
Most Relevant Literature
Targeting the Ras-ERK pathway in pancreatic adenocarcinoma.
Genetic alterations in RAS-regulated pathway in acral lentiginous melanoma.
TOR and RAS pathways regulate desiccation tolerance in Saccharomyces cerevisiae.
Targeting the RAS signalling pathway in cancer].
Cutaneous side effects of inhibitors of the RAS/RAF/MEK/ERK signalling pathway and their management.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway Mutations
NAUTILUS: OKI-179 Plus Binimetinib in Patients With Advanced Solid Tumors in the RAS Pathway (Phase …
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatme…
The Emergence of RAS Mutations in Metastatic Colorectal Cancer Patients Receiving Cetuximab Treatmen…
Rechallenge With Panitumumab Driven by RAS Dynamic of Resistance
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ